Published in Brain Res on September 18, 1995
Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain (2009) 5.62
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav (2008) 1.34
Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 1.27
Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats. Pharmacol Biochem Behav (2008) 1.07
Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice. Psychopharmacology (Berl) (2004) 0.98
Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res (2007) 0.98
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci (2002) 0.92
Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmacology (Berl) (2006) 0.92
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur J Nucl Med Mol Imaging (2005) 0.88
Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior. Drug Alcohol Depend (2013) 0.86
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res (2012) 0.86
Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle. Psychopharmacology (Berl) (2005) 0.86
Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm (Vienna) (2008) 0.85
Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig. J Pharmacol Exp Ther (2011) 0.85
Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation. Front Syst Neurosci (2014) 0.84
Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats. Pharmacol Biochem Behav (2009) 0.83
Chinese Medicine Formula "Jian-Pi-Zhi-Dong Decoction" Attenuates Tourette Syndrome via Downregulating the Expression of Dopamine Transporter in Mice. Evid Based Complement Alternat Med (2013) 0.83
Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats. J Neural Transm (Vienna) (2010) 0.80
Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism. Psychopharmacology (Berl) (2005) 0.79
Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat. J Neural Transm (Vienna) (2005) 0.78
In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience (2008) 0.77
Comparable impediment of cognitive function in female and male rats subsequent to daily administration of haloperidol after traumatic brain injury. Exp Neurol (2017) 0.75
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci (1990) 1.85
Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature (1990) 1.75
Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc Natl Acad Sci U S A (1977) 1.47
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci U S A (1991) 1.40
Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol (2007) 1.24
Metabolism of 8,11,14-eicosatrienoic acid in human platelets. Biochim Biophys Acta (1976) 1.22
Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci (1990) 1.20
Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. Anal Biochem (1981) 1.13
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biol Psychiatry (2001) 1.12
Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet (1998) 1.11
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology (1985) 1.10
Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse (2001) 1.08
Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci (1998) 1.06
Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res Brain Res Rev (2001) 1.06
Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology (1993) 1.05
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding. Brain Res (1986) 1.03
Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol (2000) 1.03
Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett (1977) 1.02
Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology (2001) 1.02
Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J Neurochem (1993) 0.98
Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology (1986) 0.95
D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA. Cell Mol Neurobiol (1991) 0.92
Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology (1987) 0.91
Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology (2000) 0.91
17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol (1985) 0.91
Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol Psychiatry (2000) 0.91
Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex. Neuroscience (1998) 0.91
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Brain Res (1995) 0.89
Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res (1997) 0.88
Pathophysiology of L-dopa-induced dyskinesias. Mov Disord (1999) 0.88
Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends Neurosci (2000) 0.87
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse (2000) 0.86
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias. Neuroscience (2010) 0.86
Norepinephrine in neonatal rat ventricular myocytes: association with the cell nucleus and binding to nuclear alpha 1- and beta-adrenergic receptors. J Mol Cell Cardiol (1993) 0.86
Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease. J Neuroendocrinol (2012) 0.86
Effects of thyroid state on serotonin, 5-hydroxyindoleacetic acid and substance P contents in discrete brain nuclei of adult rats. Neuroscience (1983) 0.86
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology (1987) 0.86
Influence of oestrogenic compounds on monoamine transporters in rat striatum. J Neuroendocrinol (2006) 0.86
Veno-venous continuous renal replacement therapy for burned patients with acute renal failure. Burns (2000) 0.85
Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels. Neuropharmacology (1980) 0.85
Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol (1981) 0.85
Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci (1988) 0.85
Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary. J Biol Chem (1988) 0.85
Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol (2005) 0.84
Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology (1992) 0.84
Effect of the rat estrous cycle at ovariectomy on striatal D-1 dopamine receptors. Brain Res Bull (1990) 0.84
Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. Neuroreport (2000) 0.84
Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett (1988) 0.83
Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr Pharm Des (2000) 0.83
Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J Neuroendocrinol (2013) 0.83
Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.83
Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy. Brain Res Bull (1999) 0.82
Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.82
Hydrogen bond breaking potency to fluorocarbon anesthetics. J Med Chem (1974) 0.82
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. J Neurochem (1999) 0.82
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys. J Pharmacol Exp Ther (1995) 0.82
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys. Adv Neurol (1993) 0.82
A physiological dose of progesterone affects rat striatum biogenic amine metabolism. Eur J Pharmacol (1986) 0.81
Striatal D1 dopamine receptor density fluctuates during the rat estrous cycle. Neurosci Lett (1989) 0.81
Molecular basis of levodopa-induced dyskinesias. Ann Neurol (2000) 0.81
Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors. J Neuroendocrinol (2008) 0.81
Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.81
Denervation supersensitivity to 5-hydroxytryptamine in the rat spinal cord is not due to the absence of 5-hydroxytryptamine. Brain Res (1985) 0.80
Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants. Neuroscience (1991) 0.80
Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study. Can J Physiol Pharmacol (1982) 0.80
In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats. Hypertension (1983) 0.80
Effects of a chronic lithium treatment on central dopamine neurotransporters. Biochem Pharmacol (1997) 0.80
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. Brain Res Mol Brain Res (1997) 0.80
Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat. Exp Brain Res (1983) 0.80
Unilateral nodular diabetic glomerulosclerosis: recurrence of an experiment of nature. Am J Nephrol (1987) 0.80
Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys. Neurosci Lett (1988) 0.80
Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int (1989) 0.80
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors. Mov Disord (1993) 0.80
Dopamine and GABAA receptor imbalance after ovariectomy in rats: model of menopause. J Psychiatry Neurosci (1995) 0.80
Structure-activity studies on odor molecules using molecular connectivity. J Theor Biol (1977) 0.80
Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience (1992) 0.79
Interaction of dehydroepiandrosterone with phospholipid membranes: an infrared spectroscopy investigation. Biochim Biophys Acta (1998) 0.79
Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors. Biochem Pharmacol (1993) 0.79
Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice. J Neuroendocrinol (2002) 0.79
Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences. Neurosci Lett (1987) 0.79
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. Eur J Pharmacol (1990) 0.79
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments. Exp Neurol (2000) 0.79
Determination of 5-hydroxytryptophan, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in 20 rat brain nuclei using liquid chromatography with electrochemical detection. Can J Physiol Pharmacol (1983) 0.79
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. Neuroscience (2001) 0.79
Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors. Life Sci (1989) 0.79
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Mol Pharmacol (1996) 0.79
Enzymatic oxidation of all-trans retinal to retinoic acid in rat tissues. Biochem Cell Biol (1988) 0.79
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys. Brain Res Mol Brain Res (1996) 0.78
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.78
Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958. Eur J Pharmacol (1999) 0.78
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Synapse (2001) 0.78
Interaction between estradiol, prolactin, and striatal dopaminergic mechanisms. Adv Neurol (1984) 0.78
Distribution of dopamine in 35 subregions of the rat caudate-putamen: a high performance liquid chromatography with electrochemical detection analysis. Can J Neurol Sci (1982) 0.78
Synthesis of prostaglandins and thromboxane B2 by cholesterol-fed rabbits. Arterioscler Thromb (1991) 0.78